Financials

  • Market Capitalization 375.4 M
  • Employee 120
  • Founded 1995
  • CEO N/A
  • Website www.enanta.com
  • Headquarter Massachusetts, United States
  • FIGI BBG001V9NSB4
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.86
Relación precio/flujo de caja
0.02

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
3121
AUTL
Autolus Therapeutics plc - American Depositary Shares
1.44 USD-0.69%-12.20%-4.00%-42.63%383.26 M USD
3122
IPSC
Century Therapeutics, Inc. - Common Stock
2.11 USD-0.94%-11.72%-8.66%+263.79%380.55 M USD
3138
XFOR
X4 Pharmaceuticals, Inc. - Common Stock
3.98 USD-1.00%+1.02%-2.93%+34.01%375.39 M USD
3142
AVIR
Atea Pharmaceuticals, Inc. - common stock
4.70 USD0.00%-4.08%+6.82%+46.42%376.13 M USD

Noticias